Corporate Education Sessions

Corporate Education Sessions

S 04 - CES Fresenius Medical Care 1 - NephroCare
     
Connecting the patient to life:
Central Venous Catheter complications can and must be managed
 
Sunday
16 September
09:00-10:30 details
S 07 - CES Gambro      
IQD – (Individualized Quality-assured Dialysis)
A guide to implementing renal best practice in haemodialysis
 
Sunday
16 September
11:00-12:30 details
S 12 - CES Baxter
     
Things You Always Wanted to Know about Dialysis
but Were Afraid to Ask
 
Sunday
16 September
14:00-15:30 details
S 19 - CES Shire
     
Balancing phosphate and protein intake in patients with CKD
 
Monday
17 September
09:00-10:30 details
S 22 - CES Fresenius Medical Care 2 - Renal Pharma
     
The future of drug management in haemodialysis
 
Monday
17 September
11:00-12:30 details
S 27 - CES Diaverum
     
Pain, anxiety, bleeding, bumps and lumps! Improving
the patients AV fistula experience
Monday
17 September
14:00-15:30 details

  

S 04 - CES Fresenius Medical Care 1 - NephroCare

Connecting the patient to life:
Central Venous Catheter complications can and must be managed

Sunday, 16 September 2012, 9:00-10:30, Erasme Hall
Additional simultaneous translation to Czech (courtesy of Fresenius Medical Care).

Introduction of the session
Cristina Miriunis (Germany)

Think ahead: Preventing the impact of Central Venous Catheter complications     
Maurizio Gallieni (Italy)

A life- preserving challenge: Pro-active care of the Central Venous Catheter to minimise complications     
Marjelka Trkulja (Croatia)

Every Choice Has A Chance of Success: Your Care Counts
Maria Teresa Parisotto (Germany)

Chair: Jean Pierre Van Waeleghem (Belgium)
 

  

S 07 - CES Gambro

IQD – (Individualized Quality-assured Dialysis)
A guide to implementing renal best practice in haemodialysis

Sunday, 16 September 2012, 11:00-12:30, Erasme Hall

Do all dialysis patients suffer from the same disease and should they receive the same prescription?
Angela Henson (Australia)

Will a technical algorithmic approach to guidelines be useful and acceptable to mostly non-technical dialysis staff?    
Frantisek Lopot (Czech Republic)

Should renal experts consult patients when they create guidelines?     
Darren Cawley (Ireland)

The last part of the Gambro Corporate Session will be supported by IQD Project Group members in leading the discussion and providing expert opinion and guidance.

Chair: Frantisek Lopot (Czech Republic)

CES Gambro

  

S 12 - CES Baxter

Things You Always Wanted to Know about Dialysis but Were Afraid to Ask

Sunday, 16 September 2012, 14:00-15:30, Erasme Hall

How do I dialyse a patient while they are waiting for a transplant?
How to clinically connect what you do today (dialysis) with the patients future option (transplant)

Claire Main (United Kingdom)

How do I manage diabetics patients on PD?
A review of techniques and tools to manage this very common group of patients without adding to their glucose load
Carlos Cruz (Portugal)

How do I stop haemodialysis patients dying on a Monday morning?
A review of High Dose HD and how it can help to avoid sudden deaths that may occur with conventional HD after a weekend without dialysis

Markku Asola (Finland)

How do I set-up a Home HD programme?
What you need to think of and do when setting up a Home HD programme. Some very practical tips

Frankie O'Kane (N. Ireland / UK)

How should I support patients to make the right treatment decision?
Structured Treatment Option Education and the use of decision aids to support patients to make the right decision with an emphasis on the principle that “Information alone” is not enough

Eva-Lena Nilsson (Sweden)

Chairs: Maria Saraiva (Portugal), Peter Rutherford (Switzerland)

CES Baxter

 

S 19 - CES Shire

Balancing phosphate and protein intake in patients with CKD

Monday, 17 September 2012, 9:00-10:30, Erasme Hall

Chair's Welcome
Denis Fouque (France)

Protein intake and phosphate control in patients undergoing dialysis
Elaine Corden (United Kingdom)

Enabling adequate protein intake: the critical role of phosphate binders
Peters Harm (Germany)

The challenge of non-adherence
Rob Horne (United Kingdom)

Chairs: Anna Marti Monros (Spain), Denis Fouque (France)

SHIRE

  

S 22 - Fresenius Medical Care 2 - Renal Pharma

The future of drug management in haemodialysis

Monday, 17 September 2012, 11:00-12:30, Erasme Hall
Additional simultaneous translation to Czech (courtesy of Fresenius Medical Care).

Typical drug therapies for patients on haemodialysis
Christoph C. Haufe (Germany)

Challenges for today's drug management procedures in daily routine
Cathy Johnson (United Kingdom)

Changing for the better – needle free i.v. drug application in the future
Marta Arias (Spain)

Chairs: Christoph C. Haufe (Germany), Alois Gorke (Germany)
 
CES FMC 2 - Invititation

  

S 27 - CES Diaverum

Pain, anxiety, bleeding, bumps and lumps! Improving the patients AV fistula experience

Monday, 17 September 2012, 14:00-15:30, Erasme Hall

Pain, anxiety, bleeding, bumps and lumps! – Improving the patients AV fistula experience
Janet Cowperthwaite (United Kingdom)

Patients’ perception of pain and anxiety during AV fistula cannulation
Filiz Akdeniz (Turkey)

The gold standard lifeline – but how do AV fistula affect patients Quality of Life
Caroline Herlin (Sweden)

Improving the patients AV fistula experience?
Nora Zajko (Hungary)

Listen to what the patients say
Mari Paz Sorribes (Spain)

Chairs: Helen Noble (UK), Janet Cowperthwaite (United Kingdom)
 
CES Diaverum

  

 

 

   
 
Conference Department: CZECH-IN s.r.o., 5. kvetna 65, 140 21 Prague 4, CZE | tel.: +420 261 174 301 | fax: +420 261 174 307 | conference2012@edtnaerca.org
Home | Sitemap
Copyright © 2011 edtna-erca-conference2012.com | Powered and created by E-WORKS - web studio | XHTML 1.0 | CSS 2